Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Centre for Process Innovation
Centre for Process Innovation
Activities:
Research & Development
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Pfizer partners with Medicines Manufacturing Innovation Centre
The company will be participating in the centre’s first ‘grand challenge,’ aiming to develop a continuous direct compression platform for oral solid dosage medicines
Research & Development
MicrofluidX makes key collaboration for microfluidics platform
CPI, MicrofluidX and the Cell and Gene Therapy Catapult have collaborated to develop bioprocessing technology for the rapid scale-up of cell and gene therapies
CPI CEO passes the torch
Nigel Perry has stepped down as CEO and will be succeeded by COO, Frank Millar
Research & Development
CPI and Oxford University join forces to lower NADH production cost
A constant feed of the expensive cofactor NADH is a requirement in many biocatalytic reactions and this has hindered industrial adoption of the technology
Ingredients
Rapid formulation stability screening platform tests real-world use
Following two years of research by CPI at Imperial College London and the University of Durham, the project is now translating the academic work into real-world applications
Ingredients
Research partnership removes bottleneck from AAV development
CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Manufacturing
Innovation centre works with pharma giants on continuous manufacturing
CPI and Strathclyde University’s strategic partnership with GSK and AstraZeneca has begun work on a continuous direct compression platform for oral solid dosage medicines
Subscribe now